MENU
+Compare
RCDTF
Stock ticker: OTC
AS OF
Jun 13 closing price
Price
$65.44
Change
+$9.40 (+16.77%)
Capitalization
10.63B

RCDTF Recordati Industria Chimica e Farmaceutica S.p.A. Forecast, Technical & Fundamental Analysis

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals... Show more

RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RCDTF with price predictions
Jul 18, 2025

Aroon Indicator for RCDTF shows an upward move is likely

RCDTF's Aroon Indicator triggered a bullish signal on July 18, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 79 similar instances where the Aroon Indicator showed a similar pattern. In of the 79 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for RCDTF turned negative on July 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 14 similar instances when the indicator turned negative. In of the 14 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.271) is normal, around the industry mean (5.632). P/E Ratio (26.110) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.026) settles around the average of (0.161) among similar stocks. P/S Ratio (4.470) is also within normal values, averaging (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCDTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.

View a ticker or compare two or three
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

RCDTF paid dividends on May 26, 2021

Recordati Industria Chimica e Farmaceutica S.p.A. RCDTF Stock Dividends
А dividend of $0.55 per share was paid with a record date of May 26, 2021, and an ex-dividend date of May 24, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Via Matteo Civitali 1
Phone
+39 2487871
Employees
4369
Web
https://www.recordati.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWLG52.160.41
+0.79%
NYLI Winslow Large Cap Growth ETF
EAGG46.960.02
+0.04%
iShares ESG U.S. Aggregate Bond ETF
MINN21.63N/A
N/A
Mairs & Power Minnesota Municipal Bd ETF
LFAR150.33N/A
N/A
LifeX 2057 Longevity Income ETF
BME35.88-0.17
-0.47%
Blackrock Health Sciences Trust

RCDTF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCDTF has been loosely correlated with VRBCF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCDTF jumps, then VRBCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCDTF
1D Price
Change %
RCDTF100%
N/A
VRBCF - RCDTF
56%
Loosely correlated
N/A
RHHBF - RCDTF
3%
Poorly correlated
-2.56%
RHHBY - RCDTF
2%
Poorly correlated
-0.80%
PTKFY - RCDTF
0%
Poorly correlated
N/A
PTKFF - RCDTF
0%
Poorly correlated
N/A
More